A carregar...

Serum lactate dehydrogenase as an early marker for outcome in patients treated with anti-PD-1 therapy in metastatic melanoma

BACKGROUND: Treatment with programmed death receptor-1 (PD-1) antibodies is associated with high response rates in patients with advanced melanoma. Reliable markers for early response and outcome are still sparse. METHODS: We evaluated 66 consecutive patients with advanced/metastatic melanoma treate...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Br J Cancer
Main Authors: Diem, S, Kasenda, B, Spain, L, Martin-Liberal, J, Marconcini, R, Gore, M, Larkin, J
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2016
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4742588/
https://ncbi.nlm.nih.gov/pubmed/26794281
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2015.467
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!